New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
Open Access
- 13 May 2003
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (10) , 1631-1640
- https://doi.org/10.1038/sj.bjc.6600925
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Involvement of Cyclo-Oxygenase-2 in Osteoclast Formation and Bone Destruction in Bone Metastasis of Mammary Carcinoma Cell LinesJournal of Bone and Mineral Research, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298Journal of Bone and Mineral Research, 2000
- Rhoa Function in Lamellae Formation and Migration Is Regulated by the α6β4 Integrin and Camp MetabolismThe Journal of cell biology, 2000
- Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing BisphosphonatesBiochemical and Biophysical Research Communications, 1999
- R-Ras Signals through Specific Integrin α Cytoplasmic Domains to Promote Migration and Invasion of Breast Epithelial CellsThe Journal of cell biology, 1999
- TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases developmentJournal of Clinical Investigation, 1999
- Rho proteins induce metastatic properties in vivoOncogene, 1997
- Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastasesXenobiotica, 1997
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889